Indeed, reactive astrocytes – classically recognizable for their hypertrophic aspect and increased expression of markers such as glial fibrillary acidic protein (GFAP) (an intermediate filament marker) – have been identified in most neurological diseases (Sofroniew, 2014). The gene discussed is GFAP; the disease is nervous system disorder.